Literature DB >> 923109

The characterization of growth hormone release inhibiting hormone-like immunoreactivity in normal urine.

S Kronheim, M Berelowitz, B L Pimstone.   

Abstract

Using a previously described radioimmunoassay for growth hormone release inhibiting hormone (GH-RIH), the presence of GH-RIH-like immunoreactivity in urine has been characterized by demonstrating mobility identical to synthetic GH-RIH standard on two sephadex gel chromatographic systems, and parallelism of dilutions of the sephadex fractions with synthetic GH-RIH. Furthermore, 74% of the sephadex fraction cross-reacting in the immunoassay bound to antibody conjugated to sepharose and could be eluted by 1 M acetic acid. This immunospecific eluate showed identity with synthetic GH-RIH on both ion exchange and thin layer chromatography. Thus GH-RIH-like immunoreactivity is present in normal urine; this may have potential relevance in the search for a physiological role for this peptide.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 923109     DOI: 10.1111/j.1365-2265.1977.tb01332.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  3 in total

1.  Hepatic and renal metabolism of somatostatin-like immunoreactivity. Simultaneous assessment in the dog.

Authors:  K S Polonsky; J B Jaspan; M Berelowitz; D S Emmanouel; J Dhorajiwala
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

2.  Somatostatin-like immunoreactivity in rat blood. Characterization, regional differences, and responses to oral and intravenous glucose.

Authors:  M Berelowitz; S Kronheim; B Pimstone; B Shapiro
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

3.  Measurement, characterization, and source of somatostatin-like immunoreactivity in human amniotic fluid.

Authors:  D Fitz-Patrick; Y C Patel
Journal:  J Clin Invest       Date:  1979-09       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.